-
IVAX Diagnostics Receives F.D.A. Clearance for Mago® 4S (IVD)
Wednesday, January 26, 2011 - 6:21pm | 77IVAX Diagnostics, Inc. (NYSE: IVD) today announced that it has received clearance from the United States Food and Drug Administration (FDA) on the 510(k) premarket submission that IVAX Diagnostics had filed for the Mago® 4S. The Mago® 4S is IVAX Diagnostics' next-generation fully-automated Enzyme-...
-
St. Jude Beats on All Fronts - Analyst Blog
Wednesday, January 26, 2011 - 5:31pm | 676Medical devices major St. Jude Medical (STJ) posted adjusted earnings per share of 75 cents for the fourth quarter and $3.01 for fiscal 2010, exceeding the Zacks Consensus Estimates of 74 cents and $2.99, respectively, and surpassing the year-ago earnings of 64 cents and $2.43, respectively. This...
-
St. Jude Beats on All Fronts - Analyst Blog
Wednesday, January 26, 2011 - 4:42pm | 676Medical devices major St. Jude Medical (STJ) posted adjusted earnings per share of 75 cents for the fourth quarter and $3.01 for fiscal 2010, exceeding the Zacks Consensus Estimates of 74 cents and $2.99, respectively, and surpassing the year-ago earnings of 64 cents and $2.43, respectively. This...
-
Unconfirmed Rumors Circulate that Delcath Systems Inc. (DCTH) will receive FDA approval on product very soon major positive for stock
Wednesday, January 26, 2011 - 2:50pm | 27Unconfirmed Rumors Circulate that Delcath Systems Inc. (DCTH) will receive FDA approval on product very soon major positive for stock..
-
NASDAQ Stocks Hitting 52-Week Highs (KEYN, IDXX, RVSN, ERIC)
Wednesday, January 26, 2011 - 11:33am | 138Keynote Systems Inc (NASDAQ: KEYN) shares gained 24.83% to create a new 52-week high of $18.70. KEYN reported upbeat Q1 earnings. IDEXX Laboratories Inc (NASDAQ: IDXX) shares surged 2.05% to create a new 52-week high of $73.54. IDXX is scheduled to report its Q4 results on January 28. RADVision Ltd...
-
Piper Jaffray Remains Buyers Of Accuray Inc. Ahead of Q2 Results
Wednesday, January 26, 2011 - 11:32am | 228Piper Jaffray remains buyers of Accuray Inc. (NASDAQ: ARAY) ahead of the company's FQ2 results scheduled to be released on Thursday evening. Piper believes there are a number of reasons to be optimistic about ARAY's future at present, including an improving US capital spending backdrop, potential...
-
Piper Jaffray Gives Earnings Preview On Varian Medical Systems
Wednesday, January 26, 2011 - 11:09am | 182Piper Jaffray expects Varian Medical Systems (NYSE: VAR) to post FQ1 results on Wednesday evening that meet or exceed current estimates. Piper's checks with private radiation therapy providers coupled with recent operating results from large capital equipment providers support its thesis for an...
-
Goldman Sachs Suggests Buying Call Spreads on BAX
Wednesday, January 26, 2011 - 10:42am | 139Goldman Sachs is out with a research note this morning, where it suggests traders buy call spreads on Baxter International (NYSE: BAX) prior to its 2011 guidance release. Goldman Sachs Medical Technology analyst, David Roman, sees CL-Buy rated BAX as his top pick in the sector with 20% upside to $...
-
Earnings Preview: Zimmer Holdings - Analyst Blog
Wednesday, January 26, 2011 - 10:31am | 834Zimmer Holdings (ZMH) is scheduled to release its fourth quarter and fiscal 2010 earnings on January 27, 2011, before the market opens. The company is expected to earn $1.19 per share on revenues of $1,108 million for the quarter and $4.26 per share on revenue of $4,198 million, for fiscal 2010,...
-
Company News for January 26, 2011 - Corporate Summary
Wednesday, January 26, 2011 - 10:31am | 872• Stryker (NYSE:SYK) reported Q4 EPS of $0.93, ahead of the Zack Consensus Estimate of $0.89 per share. Revenues for the quarter rose 8.6% to $2.0 billion, well above the Zack Consensus Estimate of $1.970 billion • Yahoo (NASDAQ:YHOO) reported Q4 EPS of $0.26, ex-items, topping Zack Consensus...
-
Stryker Beats but Concerns Linger - Analyst Blog
Wednesday, January 26, 2011 - 10:31am | 1362Orthopedic devices major Stryker Corporation (SYK) reported better-than-expected fourth-quarter fiscal 2010 results with adjusted earnings per share of 93 cents exceeding the Zacks Consensus Estimate of 90 cents and the year-ago earnings of 82 cents. For fiscal 2010, adjusted earnings of $3.33...
-
Stryker Beats but Concerns Linger - Analyst Blog
Wednesday, January 26, 2011 - 10:15am | 1362Orthopedic devices major Stryker Corporation (SYK) reported better-than-expected fourth-quarter fiscal 2010 results with adjusted earnings per share of 93 cents exceeding the Zacks Consensus Estimate of 90 cents and the year-ago earnings of 82 cents. For fiscal 2010, adjusted earnings of $3.33...
-
Company News for January 26, 2011 - Corporate Summary
Wednesday, January 26, 2011 - 10:09am | 872• Stryker (NYSE:SYK) reported Q4 EPS of $0.93, ahead of the Zack Consensus Estimate of $0.89 per share. Revenues for the quarter rose 8.6% to $2.0 billion, well above the Zack Consensus Estimate of $1.970 billion • Yahoo (NASDAQ:YHOO) reported Q4 EPS of $0.26, ex-items, topping Zack Consensus...
-
ThermoGenesis Corp. and TotipotentSC Receive Approval for Phase Ib Clinical Trial of Res-Q 60 BMC
Wednesday, January 26, 2011 - 10:02am | 47ThermoGenesis Corp. (Nasdaq: KOOL) announced today they have received approval from Fortis Escorts' (New Delhi) Independent Ethics Committee to proceed with a Phase Ib clinical trial in patients suffering from Non-Reconstructable Critical Limb Ischemia utilizing ThermoGenesis' Res-Q 60 BMC system.
-
Earnings Preview: Zimmer Holdings - Analyst Blog
Wednesday, January 26, 2011 - 10:00am | 834Zimmer Holdings (ZMH) is scheduled to release its fourth quarter and fiscal 2010 earnings on January 27, 2011, before the market opens. The company is expected to earn $1.19 per share on revenues of $1,108 million for the quarter and $4.26 per share on revenue of $4,198 million, for fiscal 2010,...